CYP1A2 (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "CYP1A2" in Italian language version.

refsWebsite

Global rank Italian rank

18nih.gov

4^th place

9^th place

16doi.org

2^nd place

7^th place

15oadoi.org

799^th place

22^nd place

1pharmvar.org

low place

1sydney.edu.au

8,221^st place

low place

1fda.gov

447^th place

644^th place

1iu.edu

3,316^th place

low place

1fass.se

low place

1drugs.com

399^th place

1,563^rd place

1drugbank.com

low place

4,124^th place

doi.org

dx.doi.org

Nelson DR, Zeldin DC, Hoffman SM, Maltais LJ, Wain HM, Nebert DW, Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants, in Pharmacogenetics, vol. 14, n. 1, Jan 2004, pp. 1-18, DOI:10.1097/00008571-200401000-00001, PMID 15128046.
Westphal C, Konkel A, Schunck WH, CYP-eicosanoids--a new link between omega-3 fatty acids and cardiac disease?, in Prostaglandins & Other Lipid Mediators, vol. 96, 1–4, Nov 2011, pp. 99-108, DOI:10.1016/j.prostaglandins.2011.09.001, PMID 21945326.
Fleming I, The pharmacology of the cytochrome P450 epoxygenase/soluble epoxide hydrolase axis in the vasculature and cardiovascular disease, in Pharmacological Reviews, vol. 66, n. 4, Oct 2014, pp. 1106-40, DOI:10.1124/pr.113.007781, PMID 25244930.
Zhang G, Kodani S, Hammock BD, Stabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancer, in Progress in Lipid Research, vol. 53, Jan 2014, pp. 108-23, DOI:10.1016/j.plipres.2013.11.003, PMID 24345640.
He J, Wang C, Zhu Y, Ai D, Soluble epoxide hydrolase: A potential target for metabolic diseases, in Journal of Diabetes, vol. 8, n. 3, Dec 2015, pp. 305-13, DOI:10.1111/1753-0407.12358, PMID 26621325.
Wagner K, Vito S, Inceoglu B, Hammock BD, The role of long chain fatty acids and their epoxide metabolites in nociceptive signaling, in Prostaglandins & Other Lipid Mediators, vol. 113-115, Oct 2014, pp. 2-12, DOI:10.1016/j.prostaglandins.2014.09.001, PMID 25240260.
Fischer R, Konkel A, Mehling H, Blossey K, Gapelyuk A, Wessel N, von Schacky C, Dechend R, Muller DN, Rothe M, Luft FC, Weylandt K, Schunck WH, Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway, in Journal of Lipid Research, vol. 55, n. 6, Mar 2014, pp. 1150-1164, DOI:10.1194/jlr.M047357, PMID 24634501.
Robert J. Fontana et al., Effects of a chargrilled meat diet on expression of CYP3A, CYP1A, and P-glycoprotein levels in healthy volunteers, in Gastroenterology, vol. 117, n. 1, luglio 1999, pp. 89-98, DOI:10.1016/S0016-5085(99)70554-8, PMID 10381914.
Marilyn C. Cornelis, Ahmed El-Sohemy e Edmond K. Kabagambe, Coffee, CYP1A2 genotype, and risk of myocardial infarction, in JAMA, vol. 295, n. 10, 8 marzo 2006, pp. 1135-1141, DOI:10.1001/jama.295.10.1135. URL consultato il 5 ottobre 2022.
Sousa MC, Braga RC, Cintra BA, de Oliveira V, Andrade CH, In silico metabolism studies of dietary flavonoids by CYP1A2 and CYP2C9, in Food Research International, vol. 50, 2013, pp. 102-110, DOI:10.1016/j.foodres.2012.09.027.
Dostalek M, Pistovcakova J, Jurica J, Sulcová A, Tomandl J, The effect of St John's wort (hypericum perforatum) on cytochrome p450 1a2 activity in perfused rat liver, in Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia, vol. 155, pp. 253-7, DOI:10.5507/bp.2011.047, PMID 22286810.
Gorski JC, Huang SM, Pinto A, Hamman MA, Hilligoss JK, Zaheer NA, Desai M, Miller M, Hall SD, The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo, in Clinical Pharmacology and Therapeutics, vol. 75, pp. 89-100, DOI:10.1016/j.clpt.2003.09.013, PMID 14749695.
Briguglio M, Hrelia S, Malaguti M, Serpe L, Canaparo R, Dell'Osso B, Galentino R, De Michele S, Dina CZ, Porta M, Banfi G, Food Bioactive Compounds and Their Interference in Drug Pharmacokinetic/Pharmacodynamic Profiles, in Pharmaceutics, vol. 10, p. 277, DOI:10.3390/pharmaceutics10040277, PMID 30558213.
Fuhr U, Klittich K, Staib AH, Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man, in British Journal of Clinical Pharmacology, vol. 35, pp. 431-6, DOI:10.1111/j.1365-2125.1993.tb04162.x, PMID 8485024.
Wen X, Wang JS, Neuvonen PJ, Backman JT, Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes., in Eur J Clin Pharmacol, vol. 57, pp. 799-804, DOI:10.1007/s00228-001-0396-3, PMID 11868802.
Zhao Y, Hellum BH, Liang A, Nilsen OG, Inhibitory Mechanisms of Human CYPs by Three Alkaloids Isolated from Traditional Chinese Herbs, in Phytotherapy Research, vol. 29, pp. 825-34, DOI:10.1002/ptr.5285, PMID 25640685.

drugbank.com

go.drugbank.com

Verapamil, su Drugbank. URL consultato il 7 ottobre 2022.
«Metabolism/Transport Effects: Substrate of CYP1A2 (minor), CYP2B6 (minor), CYP2C9 (minor), CYP2E1 (minor), CYP3A4 (major), P-glycoprotein/ABCB1; Note: Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential; Inhibits CYP1A2 (weak), CYP3A4 (moderate), P-glycoprotein/ABCB1»

drugs.com

Erlotinib, su drugs.com.
«Metabolized primarily by CYP3A4 and, to a lesser degree, by CYP1A2 and the extrahepatic isoform CYP1A1»

fass.se

Classificazione ambientale svedese dei prodotti farmaceutici - Fatti per i prescrittori (Fakta för förskrivare). Retrieved July 2011

fda.gov

(EN) Drug Development and Drug Interactions - Table of Substrates, Inhibitors and Inducers, su fda.gov, FDA. URL consultato il 7 ottobre 2022.

iu.edu

drug-interactions.medicine.iu.edu

D. A. Flockhart et al., The Flockhart Cytochrome P450 Drug-Drug Interaction Table, su drug-interactions.medicine.iu.edu, Division of Clinical Pharmacology, Indiana University School of Medicine, 2007.

nih.gov

ncbi.nlm.nih.gov

Nelson DR, Zeldin DC, Hoffman SM, Maltais LJ, Wain HM, Nebert DW, Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants, in Pharmacogenetics, vol. 14, n. 1, Jan 2004, pp. 1-18, DOI:10.1097/00008571-200401000-00001, PMID 15128046.
Jaiswal AK, Nebert DW, McBride OW, Gonzalez FJ, Human P(3)450: cDNA and complete protein sequence, repetitive Alu sequences in the 3' nontranslated region, and localization of gene to chromosome 15, in Journal of Experimental Pathology, vol. 3, n. 1, 1987, pp. 1-17, PMID 3681487.
CYP1A2 cytochrome P450 family 1 subfamily A member 2 [ Homo sapiens (human) ], su ncbi.nlm.nih.gov, National Library of Medicine, 22 settembre 2022. URL consultato il 7 ottobre 2022.
Westphal C, Konkel A, Schunck WH, CYP-eicosanoids--a new link between omega-3 fatty acids and cardiac disease?, in Prostaglandins & Other Lipid Mediators, vol. 96, 1–4, Nov 2011, pp. 99-108, DOI:10.1016/j.prostaglandins.2011.09.001, PMID 21945326.
Fleming I, The pharmacology of the cytochrome P450 epoxygenase/soluble epoxide hydrolase axis in the vasculature and cardiovascular disease, in Pharmacological Reviews, vol. 66, n. 4, Oct 2014, pp. 1106-40, DOI:10.1124/pr.113.007781, PMID 25244930.
Zhang G, Kodani S, Hammock BD, Stabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancer, in Progress in Lipid Research, vol. 53, Jan 2014, pp. 108-23, DOI:10.1016/j.plipres.2013.11.003, PMID 24345640.
He J, Wang C, Zhu Y, Ai D, Soluble epoxide hydrolase: A potential target for metabolic diseases, in Journal of Diabetes, vol. 8, n. 3, Dec 2015, pp. 305-13, DOI:10.1111/1753-0407.12358, PMID 26621325.
Wagner K, Vito S, Inceoglu B, Hammock BD, The role of long chain fatty acids and their epoxide metabolites in nociceptive signaling, in Prostaglandins & Other Lipid Mediators, vol. 113-115, Oct 2014, pp. 2-12, DOI:10.1016/j.prostaglandins.2014.09.001, PMID 25240260.
Fischer R, Konkel A, Mehling H, Blossey K, Gapelyuk A, Wessel N, von Schacky C, Dechend R, Muller DN, Rothe M, Luft FC, Weylandt K, Schunck WH, Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway, in Journal of Lipid Research, vol. 55, n. 6, Mar 2014, pp. 1150-1164, DOI:10.1194/jlr.M047357, PMID 24634501.
Robert J. Fontana et al., Effects of a chargrilled meat diet on expression of CYP3A, CYP1A, and P-glycoprotein levels in healthy volunteers, in Gastroenterology, vol. 117, n. 1, luglio 1999, pp. 89-98, DOI:10.1016/S0016-5085(99)70554-8, PMID 10381914.
R. A. Savage et al., Melatonin, StatPearls Publishing LLC, 2021.
«Ninety percent of melatonin is metabolized in the liver primarily by the enzyme CYP1A2»
Dostalek M, Pistovcakova J, Jurica J, Sulcová A, Tomandl J, The effect of St John's wort (hypericum perforatum) on cytochrome p450 1a2 activity in perfused rat liver, in Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia, vol. 155, pp. 253-7, DOI:10.5507/bp.2011.047, PMID 22286810.
Gorski JC, Huang SM, Pinto A, Hamman MA, Hilligoss JK, Zaheer NA, Desai M, Miller M, Hall SD, The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo, in Clinical Pharmacology and Therapeutics, vol. 75, pp. 89-100, DOI:10.1016/j.clpt.2003.09.013, PMID 14749695.
Briguglio M, Hrelia S, Malaguti M, Serpe L, Canaparo R, Dell'Osso B, Galentino R, De Michele S, Dina CZ, Porta M, Banfi G, Food Bioactive Compounds and Their Interference in Drug Pharmacokinetic/Pharmacodynamic Profiles, in Pharmaceutics, vol. 10, p. 277, DOI:10.3390/pharmaceutics10040277, PMID 30558213.
Fuhr U, Klittich K, Staib AH, Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man, in British Journal of Clinical Pharmacology, vol. 35, pp. 431-6, DOI:10.1111/j.1365-2125.1993.tb04162.x, PMID 8485024.
Wen X, Wang JS, Neuvonen PJ, Backman JT, Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes., in Eur J Clin Pharmacol, vol. 57, pp. 799-804, DOI:10.1007/s00228-001-0396-3, PMID 11868802.
Zhao Y, Hellum BH, Liang A, Nilsen OG, Inhibitory Mechanisms of Human CYPs by Three Alkaloids Isolated from Traditional Chinese Herbs, in Phytotherapy Research, vol. 29, pp. 825-34, DOI:10.1002/ptr.5285, PMID 25640685.

pubmed.ncbi.nlm.nih.gov

Marilyn C. Cornelis, Ahmed El-Sohemy e Edmond K. Kabagambe, Coffee, CYP1A2 genotype, and risk of myocardial infarction, in JAMA, vol. 295, n. 10, 8 marzo 2006, pp. 1135-1141, DOI:10.1001/jama.295.10.1135. URL consultato il 5 ottobre 2022.

oadoi.org

Nelson DR, Zeldin DC, Hoffman SM, Maltais LJ, Wain HM, Nebert DW, Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants, in Pharmacogenetics, vol. 14, n. 1, Jan 2004, pp. 1-18, DOI:10.1097/00008571-200401000-00001, PMID 15128046.
Westphal C, Konkel A, Schunck WH, CYP-eicosanoids--a new link between omega-3 fatty acids and cardiac disease?, in Prostaglandins & Other Lipid Mediators, vol. 96, 1–4, Nov 2011, pp. 99-108, DOI:10.1016/j.prostaglandins.2011.09.001, PMID 21945326.
Fleming I, The pharmacology of the cytochrome P450 epoxygenase/soluble epoxide hydrolase axis in the vasculature and cardiovascular disease, in Pharmacological Reviews, vol. 66, n. 4, Oct 2014, pp. 1106-40, DOI:10.1124/pr.113.007781, PMID 25244930.
Zhang G, Kodani S, Hammock BD, Stabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancer, in Progress in Lipid Research, vol. 53, Jan 2014, pp. 108-23, DOI:10.1016/j.plipres.2013.11.003, PMID 24345640.
He J, Wang C, Zhu Y, Ai D, Soluble epoxide hydrolase: A potential target for metabolic diseases, in Journal of Diabetes, vol. 8, n. 3, Dec 2015, pp. 305-13, DOI:10.1111/1753-0407.12358, PMID 26621325.
Wagner K, Vito S, Inceoglu B, Hammock BD, The role of long chain fatty acids and their epoxide metabolites in nociceptive signaling, in Prostaglandins & Other Lipid Mediators, vol. 113-115, Oct 2014, pp. 2-12, DOI:10.1016/j.prostaglandins.2014.09.001, PMID 25240260.
Fischer R, Konkel A, Mehling H, Blossey K, Gapelyuk A, Wessel N, von Schacky C, Dechend R, Muller DN, Rothe M, Luft FC, Weylandt K, Schunck WH, Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway, in Journal of Lipid Research, vol. 55, n. 6, Mar 2014, pp. 1150-1164, DOI:10.1194/jlr.M047357, PMID 24634501.
Robert J. Fontana et al., Effects of a chargrilled meat diet on expression of CYP3A, CYP1A, and P-glycoprotein levels in healthy volunteers, in Gastroenterology, vol. 117, n. 1, luglio 1999, pp. 89-98, DOI:10.1016/S0016-5085(99)70554-8, PMID 10381914.
Sousa MC, Braga RC, Cintra BA, de Oliveira V, Andrade CH, In silico metabolism studies of dietary flavonoids by CYP1A2 and CYP2C9, in Food Research International, vol. 50, 2013, pp. 102-110, DOI:10.1016/j.foodres.2012.09.027.
Dostalek M, Pistovcakova J, Jurica J, Sulcová A, Tomandl J, The effect of St John's wort (hypericum perforatum) on cytochrome p450 1a2 activity in perfused rat liver, in Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia, vol. 155, pp. 253-7, DOI:10.5507/bp.2011.047, PMID 22286810.
Gorski JC, Huang SM, Pinto A, Hamman MA, Hilligoss JK, Zaheer NA, Desai M, Miller M, Hall SD, The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo, in Clinical Pharmacology and Therapeutics, vol. 75, pp. 89-100, DOI:10.1016/j.clpt.2003.09.013, PMID 14749695.
Briguglio M, Hrelia S, Malaguti M, Serpe L, Canaparo R, Dell'Osso B, Galentino R, De Michele S, Dina CZ, Porta M, Banfi G, Food Bioactive Compounds and Their Interference in Drug Pharmacokinetic/Pharmacodynamic Profiles, in Pharmaceutics, vol. 10, p. 277, DOI:10.3390/pharmaceutics10040277, PMID 30558213.
Fuhr U, Klittich K, Staib AH, Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man, in British Journal of Clinical Pharmacology, vol. 35, pp. 431-6, DOI:10.1111/j.1365-2125.1993.tb04162.x, PMID 8485024.
Wen X, Wang JS, Neuvonen PJ, Backman JT, Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes., in Eur J Clin Pharmacol, vol. 57, pp. 799-804, DOI:10.1007/s00228-001-0396-3, PMID 11868802.
Zhao Y, Hellum BH, Liang A, Nilsen OG, Inhibitory Mechanisms of Human CYPs by Three Alkaloids Isolated from Traditional Chinese Herbs, in Phytotherapy Research, vol. 29, pp. 825-34, DOI:10.1002/ptr.5285, PMID 25640685.

pharmvar.org

CYP1A2 allele nomenclature, su PharmVar. URL consultato il 7 ottobre 2022.

sydney.edu.au

Sanday, Kate, http://sydney.edu.au/news/pharm/1311.html?newsstoryid=7969.